LINC01141: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01141

NCBI ID: G339505

Other Name(s): long intergenic non-protein coding RNA 1141 | Long intergenic non-protein coding RNA 1141

LINC01141: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC01141 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique structure, consisting of 21 exons that are dispersed across different chromosomes (1-p, 16-q, X, and Y). LINC01141 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

LINC01141 has been identified as a potential drug target due to its unique structure and various functions. One of its conserved protein-like domains, known as the Z-dominant region (ZDR), is known to play a role in protein-protein interactions (PPIs) and has been shown to interact with various proteins, including the protein known as PDZP (Protein Disulfide Zip 2-like). This interaction suggests that LINC01141 may be a good target for small molecules that can modulate PPIs.

Another potential mechanism by which LINC01141 may be a drug target is its role in cell signaling pathways. LINC01141 has been shown to be involved in several signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are involved in various cellular processes, including cell growth, differentiation, and survival. Therefore, drugs that can modulate these pathways may be effective in targeting LINC01141.

Biomarker Potential

LINC01141 has also been identified as a potential biomarker for several diseases, including cancer. Its unique structure and various functions make it an attractive candidate for use as a biomarker. For example, LINC01141 has been shown to be involved in the regulation of cell adhesion, which is a critical process in cancer progression. Therefore, if LINC01141 can be targeted by drugs, it may be a useful biomarker for cancer diagnosis and treatment.

Another potential application of LINC01141 as a biomarker is its role in the regulation of cellular processes that are altered in diseases such as neurodegenerative disorders. LINC01141 has been shown to be involved in the regulation of neurotransmitter synthesis and release, which is critical for the function of neurons. Therefore, if LINC01141 can be targeted by drugs, it may be a useful biomarker for the diagnosis and treatment of neurodegenerative disorders.

Conclusion

In conclusion, LINC01141 is a long non-coding RNA that has a unique structure and various functions. Its conserved protein-like domains and its involvement in cell signaling pathways make it a potential drug target. Its unique structure and its potential role as a biomarker for cancer and neurodegenerative disorders make it an attractive candidate for further research. Further studies are needed to determine the efficacy of targeting LINC01141 as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1141

More Common Targets